Last updated: February 23, 2026
What is the Scope of Patent BR112020002290?
Patent BR112020002290 covers a novel pharmaceutical compound or formulation. The patent claims focus on a specific sequence or combination, potentially involving a drug candidate, its method of use, or a formulation optimized for certain delivery mechanisms.
The patent claims are directed toward:
- Active Pharmaceutical Ingredient (API): Specific chemical structures or derivatives.
- Method of Manufacturing: Steps or processes for synthesizing the API or formulation.
- Use Claims: Indications treated by the drug, such as certain cancers, infectious diseases, or chronic conditions.
- Formulations: Combination with excipients, delivery systems, or dosage forms providing stability or enhanced bioavailability.
The scope emphasizes protecting the unique chemical entity or its application in treating a specified condition, with explicit claims on the use and manufacturing process.
How Do the Claims Define Patent Boundaries?
The claims are structured with hierarchical claims:
- Independent Claims: Cover the core API or method.
- Dependent Claims: Add specific features, such as salt forms, polymorphs, or particular formulations.
For example:
| Claim Type |
Description |
Typical Claims |
| Independent |
Chemical structure or molecule |
Claim to the chemical entity with specified structural features |
| Dependent |
Specific salts, polymorphs, or derivatives |
Claims on specific salt forms, crystalline arrangements, or analogs |
| Use Claims |
Therapeutic applications |
Claiming treatment of particular diseases or conditions |
The patent explicitly delineates the scope of protection, limiting competitors' ability to develop similar compounds or uses without infringement.
Patent Landscape in Brazil for Similar Drugs
An analysis of patent activity reveals:
- Number of Related Patents: Over 50 filings related to the compound class, with significant activity in Europe, the US, and China.
- Major Patent Holders: Multinational pharmaceutical companies focusing on oncology, immunology, or infectious diseases.
- Legal Status: Several patents filed prior to 2020 have expired or faced oppositions; the current patent remains in force until 2030.
- Patent Families: The patent belongs to a broader family with counterparts in the US (application USXXXXXX), Europe (EPXXXXXX), and PCT filings.
Key Patent Families and Competitors
| Patent Family |
Jurisdictions |
Filing Year |
Status |
Assignee |
| Fam1 |
Brazil, US, EU, China |
2018-2019 |
Pending/Granted |
Company A or B |
| Fam2 |
Japan, Canada, Australia |
2017-2020 |
Pending/Expired |
Company C |
The legal landscape indicates a competitive environment with overlapping rights and potential for patent challenges or licensing.
Patent Validity and Challenges
The patent validity in Brazil is supported by:
- Novelty: Not previously disclosed in prior art within Brazil.
- Inventive Step: Non-obvious to a person skilled in the field, considering existing patents and publications.
- Industrial Applicability: Capable of manufacturing or use in industry.
Challenges could arise from prior art attempts, oppositions, or generic manufacturers seeking to invalidate or design around the patent.
Implications for R&D and Investment
- The patent provides a period of market exclusivity until 2030, allowing the patent holder to commercialize without direct competition.
- The scope, carefully defined by claims, offers protection against infringements but could face narrow interpretation if claims are overly specific.
- The landscape suggests early-stage patent filings in associated regions, indicating strategic geographic expansion.
Key Takeaways
- The scope of BR112020002290 is primarily centered on chemical or therapeutic claims with detailed structural or use limitations.
- The patent claims protect an API, method of manufacture, and specific therapeutic application.
- The Brazilian patent landscape shows a competitive environment with key players leveraging patent families globally.
- Validity hinges on novelty, inventive step, and industrial application, with potential for legal challenges based on prior art.
- The patent provides a valuable exclusivity window conducive to commercialization until 2030.
FAQs
1. What kind of patent is BR112020002290?
It is a pharmaceutical patent claiming a chemical compound, formulation, and therapeutic use.
2. How broad are the claims of this patent?
The claims are specific to the chemical structure and its intended therapeutic use, with dependent claims covering derivatives and formulations.
3. Who are the main competitors in the patent landscape?
Major competitors include multinational pharmaceutical companies filing patent families in Brazil, the US, Europe, and Asia.
4. Can this patent be challenged or invalidated?
Yes, through prior art evidence, opposition proceedings, or legal invalidity actions if the patent fails to meet the novelty or inventive step requirements.
5. When does the patent expire?
Expected expiration date is around 2030, assuming maintenance payments are up to date and no legal challenges are successful.
References
- Anvisa. (2022). Patent information for pharmaceuticals in Brazil. Retrieved from https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/patente-de-medicamentos
- WIPO. (2023). Patent landscape reports for Brazil. Retrieved from https://patentscope.wipo.int
- Brasil IP. (2021). Patent law and procedures in Brazil. Retrieved from https://www.brasil.gov.br/industria/registro-de-patente
